[The use of Emdogain in periodontal and osseous regeneration]

There is no fulltext present in this item.

Title:	[The use of Emdogain in periodontal and osseous regeneration]
Author(s):	Sculean, A. ; Rathe, F.; Junker, R. ; Becker, J.; Schwarz, F.; Arweiler, N.B.
Publication year:	2007
Source:	Schweizer Monatsschrift für Zahnmedizin, vol. 117, iss. 6, (2007), pp. 598-606
ISSN:	1011-4203
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/53489
Display more details
Subject:	NCMLS 1: Immunity, infection and tissue repair UMCN 4.3: Tissue engineering and reconstructive surgery
Organization:	Periodontology and Biomaterials
Journal title:	Schweizer Monatsschrift für Zahnmedizin
Volume:	vol. 117
Issue:	iss. 6
Page start:	p. 598
Page end:	p. 606
Abstract:	The goal of regenerative periodontal therapy is the reconstitution of the lost periodontal structures (i. e. the new formation of root cementum, periodontal ligament and alveolar bone). Results from basic research have pointed to the important role of an enamel matrix protein derivative (EMD) in periodontal wound healing. Histological results from experiments in animals and from human case reports have shown that treatment with EMD promotes periodontal regeneration. Moreover, clinical studies have indicated that treatment with EMD positively influences periodontal wound healing in humans. The goal of the current overview is to present the clinical indications for regenerative therapy with EMD based on the existing evidence.